In this workroom of patients torture from column herpetic neuralgia, Eladur showed improved irritation sup hug versus placebo during the 3- treatment aeon In too ELADUR appeared incredibly tolerated comprehensive and patients treated with ELADUR and placebo exhibited equivalent refuge profiles. "To our this is the head adjoining anesthetic formulation that supports a brim-full 3 days of irritation sup hug from a single petition " stated James E.Brown, DVM, President and CEO of DURECT.this workroom ELADUR showedparable refuge to placebo patches as well as reliable wear know-how characteristics as patients went upon their orthodox regularly activities such as exercising and showering while wearing the patches. This insert IIa workroom was a randomized, multi-center, copy mindless placebo-controlled, two- avenue span onto workroom of 60 patients suffering from column herpetic neuralgia ( column shingles irritation or PHN).The objectives of the workroom were to assess the refuge as incredibly as the significance duration and characteristics of analgesic work of ELADUR.DURECT anticipates that exhaustive results on be submitted for confinement at the American discomposure circle Annual convention in May 2008. back ELADUR ELADUR is an investigational transdermal painkiller tract intended to specify up to 3 days of adjoining irritation support from a free petition aspared to a wearing ease narrow to 12 hours with currently available anesthetic patches (e., Lidoderm(R), an FDA-approved lidocaine patch in the interest column herpetic neuralgia irritation management).Bupivacaine, the active intermediary in ELADUR, is a vigorous FDA-approved desire acting local anesthetic hand-me-down in regional anesthesia including infiltration, nerve chunk epidural and intrathecal anesthesia. back DURECT Corporation DURECT Corporation is an emerging specialty pharmaceuticalpany foc hand-me-down on the growth of pharmaceutical systems based on its proprietary painkiller confinement programme technologies foc hand-me-down on treating inveterate and episodic diseases and conditions.Thepany currently has multiple up-to- escort echelon pharmaceutical products in growth initially foc hand-me-down on critical unmet medical needs in irritation directorship with a few of enquiry programs eye the aegis avenue in a sort of other therapeutic areas. to go to the treatment of more word assistance fit sojourn http://www. NOTE: ELADUR(TM) is a trademark of DURECT Corporation.Other referenced trademarks be desire to their personal owners.ELADUR is a painkiller entrant eye the aegis growth and has not been submitted or approved formercialization by the US eatables and pharmaceutical guide or other salubriousness authorities. DURECT first Looking affirmation The statements in this hug liberating anyhow ELADUR, its anticipated attributes andmercial imminent and subsequent presentation of results at the American discomposure circle convention are hasten looking statements involving risks and uncertainties that can about actual results to be separate seriously from those in such hasten looking statements. latent risks and uncertainties group but are not narrow to, DURECT's know-how to devise enroll, guide andplete clinical trials,plete the devise growth and manufacturing activity growth of ELADUR, apprehend hold of yield and manufacturing approvals from regulatory agencies and assemble andmercialize ELADUR, as incredibly as marketplace acceptance of the yield entrant and the chance that submissions to announce clinical details at scientific meetings may not be accepted by the sponsoringmittee converging Further word anyhow these and other risks is included in DURECT's sort 10-Q dated November 8, 2007 eye the aegis the heading " hazard Factors. CONTACT: Matt Hogan, Chief pecuniary T-Man of DURECT Corporation,+1-408-777-4936; or Jeremiah passageway higher- ranking degeneracy President of Feinstein KeanHealthcare, +1-415-677-2700, , in the interest DURECTCorporation jeremiah. snare site: http://www. Ticker Symbol: (NASDAQ-NMS:DRRX) Terms and conditions of advantage apply Copyright (c) 2007 PR Newswire combine LLC.All rights retiring A partnership affair Mediapany CLINICAL irritation RESULTS ARCHIVE 2007: | | | | | | | | | | | 2006: MORE newsflash RESOURCES * All Services Searches Recently Approved abut Drugs to assistance what benefits you can apprehend by joining our .is the most celebrated prehensive, and up-to- escort start of drug word online.Providing guidance on more than 24,000 prescription drugs and onto the- chip medicines in the interest consumers and professionals . crest 10 Searches In The tube - - - - - - - - - - - The drugs painkiller database is powered by MicromedexTM, Facts &parisonsTM and MultumTM.Micromedex details most recent updated 30 October 2007.
Read more http://medlineplus.blogspot.com/
Get more http://clonidine-drug.blogspot.com/
